TenQ · Equity ReportCharts view ⇢  Fact sheet  Updated 2026-09-04

Dollar GeneralDG

$29.4B market cap

Runs thousands of small discount stores in rural and small-town America.

$133.21-13.9% from 52-week high · delayed close as of 2026-09-04 · not investment advice
+24.4% vs S&P 500 (SPY) +20.3% over twelve months
$89.79$107.22$124.66$142.09$159.52Sep '25Nov '25Jan '26Apr '26Jun '26Sep '26
The verdict

Dollar General in 36 checks

Dollar General at a glance: how it scores on value, growth, quality, health, shareholder returns and trend. The fuller the shape, the stronger the company. Behind each axis are six pass-or-fail checks from its filings, spelled out in the chapters below. Point at an axis to see them.

VALUEGROWTHQUALITYHEALTHRETURNSTREND

A mixed picture - strengths and real weaknesses - 20 of 36 checks passed.

Advertisement
I

Value

●●●●●●3/6

What you pay today for what the business produces, measured against DG's own history and its peers, never a universal rule.

Fairly priced on some measures, rich on others - earnings multiple below its own long-run norm.

17.3xown 6-year median 19x
0.7xown 6-year median 1x
6.8%cash earned per $ of price
9.2xwhole-business multiple
Today’s multiple

Is the price high or low right now, compared to what the market usually pays?

6-year median 19xP/E today 17.3x

At 17.3x earnings, the market is paying about what it has typically paid DG's own 6-year median of 19.1x. Neither a bargain nor a stretch by its own standard.

Valuation history

What has the market paid for DG over the years?

0.0010.0020.0020152019202020212024202520266-year median 19.1xP/E 17.27

2026 = at the latest close (2026-09-04), over the trailing twelve months; earlier years are annual averages

At 17.3x earnings, the market is paying about what it has typically paid DG's own 6-year median of 19.1x. Neither a bargain nor a stretch by its own standard.

Free cash flow yield

What cash return does the business throw off per dollar of market value?

6.8%FCF yield today

0.0%5.0%10%20152019202020212024202520266-year median 6.5%FCF yield 6.8%

2026 = at the latest close (2026-09-04), over the trailing twelve months; earlier years are annual averages

At 6.8%, the business is throwing off more cash per dollar of market value than its own 6-year median of 6.5% - the cheaper end of its history.

What does “Value” actually mean?

Value asks what you pay for each dollar of earnings, sales or cash the business produces. A high multiple isn't automatically bad - fast growers earn theirs - but a price far above the company's own history means the market expects a lot to go right. We compare each multiple to the company's own past and to its sector, never to a universal rule.

How we scored it · 3 of 6 checks passed
Cheaper than its own history (earnings)no multiple history
Earnings yield beats a long bond (4%)5.8% vs 4.0%
Better cash yield than its own historyunder 3 years of cash-flow history
Free cash flow yield above 3%6.8% vs 3.0%
Cheap on enterprise value9.18 vs 14.00 (peer median)
Price isn't outrunning growthno positive three-year earnings growth behind the price
II

Growth

●●●●●●2/6

What the company has actually reported - is it selling more, and is more of it becoming profit?

Growth is weak or inconsistent - the trend, not the story, is the problem.

+4.8%vs the year before
-compound annual
+43.0%net income growth
-compound annual
Revenue history

Revenue: is the business selling more than it used to?

0.00$20.0B$40.0B20092010201320142015201920202021202420252026$43.6B

◌ 2026 = trailing twelve months to the latest filed quarter, not a full fiscal year

Revenue reached $42.7B in 2025, compounding +6% a year since 2021 though the pace has cooled. The trailing twelve months are already running at $43.6B, ahead of the last full year.

Profit history

Net income: how much of that revenue becomes profit?

0.00$1.0B$2.0B2009201020132014201520192020$2.7B2021202420252026$1.7B

◌ 2026 = trailing twelve months to the latest filed quarter, not a full fiscal year

Net income was $1.5B in 2025, compounding -11% a year over three years. Earnings per share moved +43% over the last twelve months. Trailing twelve-month profit stands at $1.7B.

Growth rate

How fast is it growing, year by year?

+5%revenue growth, FY 2025

0.0%2010201320142015201920202021202420255.2%34%

In 2025 revenue grew +5% while earnings moved +34% - when the earnings line runs above revenue, each new dollar of sales is arriving more profitably.

Per-share growth

Revenue per share: is your slice growing as fast as the company?

$193.49revenue per share, FY 2025

0.00100200200920102013201420152019202020212024202520261989.11

2026 = trailing twelve months to the latest filed quarter (2026-07-31), not a full fiscal year

Revenue per share reached $193.49 in 2025, compounding +7% a year against +6% for DG as a whole. Buybacks added roughly 1.8 points to your per-share result. Free cash flow per share stands at $10.84.

What does “Growth” actually mean?

Growth here is what the company has actually reported to the SEC - not a forecast. We look at the last year, the three-year pace, whether growth is speeding up or slowing down, and whether it's been consistent rather than one lucky year. Hatched bars are fourth quarters we derived from annual filings (companies file a full-year 10-K rather than a Q4 report).

How we scored it · 2 of 6 checks passed
Outgrew its sector last year4.8% vs 11.3% (market 70th pct)
Sustained growth beats its sector (3 years)under 3 years of history
Profits grew last year43.0% vs 0.0%
Profit growth beats its peersprofitable now after losses three years ago
Growth is speeding up, not slowingunder 3 years of history
Grew per share, not just in totalunder 3 years of per-share history
III

Quality

●●●●●●3/6

Whether the growth makes real money - margins, returns on capital, and whether profits turn into cash.

A solidly profitable business, though not exceptional against its sector.

31.2%kept after direct costs
5.6%kept after running costs
18.3%profit on shareholders' money
9.8%against a 10% cost of capital
195%operating cash ÷ net income
Margins

Margins: of every $1 of sales, how much survives each cost layer?

0.0%20%2009201020132014201520192020202120242025202631%5.6%3.9%

2026 = trailing twelve months to the latest filed quarter (2026-07-31), not a full fiscal year

Operating margin has held near 5% since 2024. After everything, 4 cents of each sales dollar reaches net profit.

Earnings quality

Earnings quality: do the reported profits turn into real cash?

0.00$2.0B$4.0B20092010201320142015201920202021202420252026$3.3B$1.7B

2026 = trailing twelve months to the latest filed quarter (2026-07-31), not a full fiscal year

Operating cash flow runs at 195% of reported profit, so the earnings are more than backed by cash - depreciation and other non-cash charges are understating what the business actually collects.

Returns on capital

What does it earn on the money it uses?

0.0%20%40%2009201020132014201520192020202120242025202618%5.3%9.2%

2026 = trailing twelve months to the latest filed quarter (2026-07-31), not a full fiscal year

ROE of 18% but ROCE of only 9% - a chunk of those shareholder returns is manufactured with leverage, not operations.

Income waterfall

Where does each dollar of revenue actually go?

$42.7BRevenue 2025$13.1BGross profit$2.2BOperating income$1.5BNet income

Of $42.7B in sales, $13.1B survives production costs, $2.2B survives running the company, and $1.5B - 4¢ of every dollar - reaches the bottom line.

Cash conversion

How much of every sales dollar ends up as free cash?

0.0%5.0%20092010201320142015201920208.4%20212024202520264.6%

◌ 2026 = trailing twelve months to the latest filed quarter, not a full fiscal year

6 cents of every sales dollar became free cash in 2025, and it has held steady since 2024.

Spending intensity

What does staying competitive cost, per dollar of sales?

0.0%2.0%200920102013201420152019202020212024202520263.0%0.2%

2026 = trailing twelve months to the latest filed quarter (2026-07-31), not a full fiscal year

The biggest claim on each sales dollar is capital spending, at 3% of revenue (stock compensation 0%).

Operating leverage

When sales grow, do profits grow faster?

-50%0.0%50%2010201320142015201920202021202420255.2%29%

Operating profit outgrew revenue in only 2 of the last 5 years. Costs are growing roughly in step with the business, so scale isn't yet paying for itself.

Return on capital employed

Does DG earn more on its capital than that capital costs?

0.0%10%20%20102013201420152019202020212024202510% cost-of-capital lineReturn on capital 9.2%

DG earns 9.2% on the capital it employs, below the 10% most investors treat as the cost of capital. It was 15.8% in 2021, so the trend is down, though the pace has cooled.

What does “Quality” actually mean?

Quality asks whether the growth makes real money. Margins show how much of each sale survives costs; return on equity shows what shareholders earn on their capital; and the profit-to-cash comparison catches companies whose accounting profits never turn into actual cash.

How we scored it · 3 of 6 checks passed
Better gross margins than peers31.2% vs 52.5% (market 70th pct)
Runs leaner than peers (operating margin)5.6% vs 13.0% (market 70th pct)
Actually profitableTTM net income $1.7B
Earns well on shareholders' money18.3% vs 12.3% (market 70th pct)
Earns a real return on the capital it employs9.8% vs 10.0%
Profits are cash, not accounting1.95 vs 0.80
IV

Health

●●●●●●4/6

The balance sheet stress test: could DG survive a bad year?

Financially sound overall, with one or two things worth watching.

0.49xborrowed vs owned
1.2xnear-term bills coverage
7xearnings ÷ interest bill
$1.6Bcash plus short-term investments
Debt & cash

Could it handle its debt if things went wrong?

0.00$5.0B201220132014201520162017201820192020202120222023202420252026$4.6B$1.6B

Debt of $4.6B sits against $1.6B of cash, or 0.5x shareholders' equity. Earnings cover interest 7.5 times - adequate, with less room than it looks in a downturn.

Shareholders' equity

Is the company's own capital growing or shrinking?

0.00$5.0B201220132014201520162017201820192020202120222023202420252026$9.3B

The company's own capital grew from $6.7B in 2023 to $9.3B (+38%). The business is building book value rather than consuming it.

What does “Health” actually mean?

Health asks one question: can the business survive a bad year? We check whether near-term bills are covered, whether debt is modest and shrinking, whether earnings comfortably pay the interest, and - for loss-makers - how many years of cash are left at the current burn rate.

How we scored it · 4 of 6 checks passed
Comfortable near-term liquidity1.21 vs 1.50
Debt isn't dominating0.49 vs 1.00
Debt trending the right waydebt/equity 0.49 now vs 0.67 five years ago
Earnings cover the interest7.47 vs 5.00
Converts sales to cash better than its sector7.6% vs 20.5% (market 70th pct)
Self-fundingTTM free cash flow $2.0B
V

Shareholder returns

●●●●●●3/6

How much cash actually flows back to owners - dividends, buybacks, whether the share count truly falls, and whether what is handed back is affordable.

Cash comes back to owners, with a caveat or two in the checks below.

$3.3Bdividends plus buybacks
$520Mlast fiscal year
$2.7Blast fiscal year
$91Mdilutes the buybacks
-32.0%since 2009 (as reported)
Capital returned vs stock comp

How much goes back to shareholders - and how much leaks out as stock compensation?

0.00$1.0B$2.0B201120122016201720182022

$3.3B returned last year against $91M of stock issued to employees - the returns outweigh the dilution 35.7-to-1.

Dilution rate (split-adjusted)

How fast is your ownership being diluted - or concentrated?

-10%0.0%20106.1%201320142015201920202021202420250.4%

0.4% more shares last year - your stake was diluted by that much.

Dividend per share (split-adjusted)

Is the dividend cheque itself growing?

0.001.002.002009201520192020202120242025DPS 2.35

Up from $0.88 to $2.35 per share over 10 years - the cheque keeps growing.

Dividend yield

What does the payout earn you at each year's prices?

0.0%1.0%2.0%2015201920202021202420252026Yield 1.8%

2026 = at the latest close (2026-09-04), over the trailing twelve months; earlier years are annual averages

At today's price the yield is 1.8%.

Payout quality

Can it actually afford the dividend?

0.0%25%50%2009201520192020202120242025202630%26%

2026 = trailing twelve months to the latest filed quarter (2026-07-31), not a full fiscal year

Comfortable: 34% of profits and 22% of free cash flow go out as dividends - well inside what the business generates.

Dilution against what it bought

DG has issued or retired shares - did shareholders end up better off?

0200400200920102013201420152019202020212024202568533

Both lines start at 100 in 2009, so the gap between them is what each share gained or lost. Share counts are split-adjusted.

DG has shrunk its share count -32% from 2009 to 2025, so each remaining share owns more of the business. Revenue per share is +433% over the same years.

Why compare buybacks with stock compensation?

A company can trumpet billions in buybacks while quietly issuing nearly as much stock to employees. What matters to you is the net effect: is the share count actually falling? If not, the 'return' is mostly recycling.

How we scored it · 3 of 6 checks passed
Share count isn't climbingunder 3 years of share counts
Buybacks outpace the stock issued to staff$2.7B bought back vs $100M of stock compensation
What it hands back fits inside its cash flow162.5% vs 100.0%
Meaningful yield to owners (dividends and buybacks)$3.3B returned, 11.1% of market value
Reliable payer, never cutpaid 7/10 years, worst year-on-year change 0.1%
Dividend growing ahead of inflation46.0% vs 9.0%
VI

Trend analysis

●●●●●5/6

What the market is doing about all of the above. This is price behaviour, not a fact about the business - read it as the market's current opinion, scored on six checks like every other chapter. The market is the S&P 500, measured by the SPY ETF with dividends included, over 3 months (63 trading sessions) and 12 months (252).

The market agrees: the stock is in a healthy uptrend on every horizon.

+6.4%the long-term trend line
+29.1%S&P 500 (SPY): +4.7%
+25.3%S&P 500 (SPY): +20.0%
-13.9%drawdown from peak
Trend

How is DG's trend actually behaving right now?

Price chart loads as you scroll…

Chart by TradingView

DG is in a clear uptrend. The price is above the band where recent trading settled, and that band is still rising underneath it, so the floor keeps moving up. It has held that side of the band for 42 sessions, so this is well established. The last two weeks are running ahead of the last month and the price is above where it stood a month ago, so the shorter-term readings back the trend up.

How the trend above is worked out

The trend read comes from the daily Ichimoku picture, a standard trend indicator, translated out of its jargon. It builds a band from the midpoints of the last 9, 26 and 52 sessions' highs and lows - in effect, the range where recent trading has settled - and draws that band 26 sessions into the future. Price above the band is an uptrend, below it a downtrend, inside it no trend. Because the band is drawn forward, the support for the next few weeks is already fixed and a change of its direction can be seen coming. We also compare the last two weeks against the last month, and today's price against where it stood a month ago. None of this says anything about the business; it describes the price only, and it is not advice. Where a check says 'the S&P 500', the comparison is with the SPY ETF including dividends, on the same adjusted basis as the stock's own price: short means 3 months, 63 trading sessions; long means 12 months, 252.

How we scored it · 5 of 6 checks passed
Trading above its cloud1.00 vs 0.50
Long-term trend structure is healthy122.74 vs 125.21
Rising over 3 months29.1% vs 0.0%
Beating the S&P 500 over 3 months29.1% vs 4.7%
Beating the S&P 500 over 12 months25.3% vs 20.0%
Not in a deep hole-13.9% from its 52-week high
VII

Insider activity

informational

What the people running the company do with their own shares - reported to the SEC within two days, classified so pay-plumbing doesn't masquerade as conviction.

$0.00their own money
$3Moften pre-scheduled
4of the last filings
46grants · exercises · tax
Open-market flow

Are the people running it buying or selling with their own money?

$2M$1M0.00Dec '25Sep '26

No open-market buying, and $3M of selling across 2 months. Selling alone is a weak signal - much of it is pre-scheduled - but the absence of buying tells you no insider saw the price as a bargain.

The record

Who did what, exactly?

DateInsiderRoleTypeSharesValue
2026-09-03Kathleen A ReardonEVP & Chief People OfficerSELL5,578$732,555
2026-05-28Kathleen ScarlettDirectordisposition0$35.81
2026-05-28Ralph E SantanaDirectordisposition0$35.81
2026-05-28Debra A. SandlerDirectordisposition0$35.81
2026-05-28Timothy I McguireDirectordisposition0$35.81
2026-05-28Ana Maria ChadwickDirectordisposition0$35.81
2026-05-28Warren F BryantDirectordisposition1$141.23
2026-04-01Anita C ElliottSVP & Chief Accounting Officertax1,303$152,673
2026-04-01Bryan D WheelerEVP & Chief Merchandising Ofctax902$105,687
2026-04-01Roderick J WestEVP, Global Supply Chaintax8,017$939,352
Why do the transaction types matter so much?

Most insider filings are not trades: stock grants, option exercises and tax withholding are how executives get paid, and gifts are estate planning. The signal lives in open-market transactions - a buy means an insider chose to spend their own cash on the stock. Sells are murkier: many are pre-scheduled 10b5-1 plans set months in advance. That's why the chart counts only open-market activity, and the table labels every row.

§

Recent filings

  • 10-Q Quarterly report
  • 10-Q Quarterly report
  • DEF 14A Proxy statement
  • 10-K Annual report
  • 10-Q Quarterly report
  • 10-Q Quarterly report
  • 10-Q Quarterly report
  • DEF 14A Proxy statement
A short weekly note on what changed in the numbers, coming soon.One email a week: the charts that mattered, nothing else.